These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 37916438)
1. Lectin-anticancer peptide fusion demonstrates a significant cancer-cell-selective cytotoxic effect and inspires the production of "clickable" anticancer peptide in Escherichia coli. Pasupuleti R; Riedl S; Saltor Núñez L; Karava M; Kumar V; Kourist R; Turnbull WB; Zweytick D; Wiltschi B Protein Sci; 2023 Dec; 32(12):e4830. PubMed ID: 37916438 [TBL] [Abstract][Full Text] [Related]
2. Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells. Wodlej C; Riedl S; Rinner B; Leber R; Drechsler C; Voelker DR; Choi JY; Lohner K; Zweytick D PLoS One; 2019; 14(1):e0211187. PubMed ID: 30682171 [TBL] [Abstract][Full Text] [Related]
3. Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine. Riedl S; Leber R; Rinner B; Schaider H; Lohner K; Zweytick D Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2918-31. PubMed ID: 26239537 [TBL] [Abstract][Full Text] [Related]
4. Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies. Grissenberger S; Riedl S; Rinner B; Leber R; Zweytick D Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183264. PubMed ID: 32151609 [TBL] [Abstract][Full Text] [Related]
5. Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine. Riedl S; Rinner B; Schaider H; Lohner K; Zweytick D Biometals; 2014 Oct; 27(5):981-97. PubMed ID: 24838743 [TBL] [Abstract][Full Text] [Related]
6. A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. Rosato F; Pasupuleti R; Tomisch J; Meléndez AV; Kolanovic D; Makshakova ON; Wiltschi B; Römer W J Transl Med; 2022 Dec; 20(1):578. PubMed ID: 36494671 [TBL] [Abstract][Full Text] [Related]
7. Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry. Szymczak-Kulus K; Weidler S; Bereznicka A; Mikolajczyk K; Kaczmarek R; Bednarz B; Zhang T; Urbaniak A; Olczak M; Park EY; Majorczyk E; Kapczynska K; Lukasiewicz J; Wuhrer M; Unverzagt C; Czerwinski M J Biol Chem; 2021; 296():100299. PubMed ID: 33460651 [TBL] [Abstract][Full Text] [Related]
9. A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells. Tomisch J; Busse V; Rosato F; Makshakova ON; Salavei P; Kittel AS; Gillon E; Lataster L; Imberty A; Meléndez AV; Römer W Cells; 2023 Jul; 12(14):. PubMed ID: 37508560 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms. Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536 [TBL] [Abstract][Full Text] [Related]
11. Expression, purification, characterization, and cytotoxic evaluation of the ML1-STxB fusion protein. Yousefi MH; Afkhami H; Akbari A; Honari H Arch Microbiol; 2023 May; 205(6):220. PubMed ID: 37148384 [TBL] [Abstract][Full Text] [Related]
12. Genetic code expansion in E. coli enables production of a functional 'ready-to-click' T cell receptor-specific scFv. Pasupuleti R; Rosato F; Kolanovic D; Makshakova ON; Römer W; Wiltschi B N Biotechnol; 2023 Sep; 76():127-137. PubMed ID: 37257818 [TBL] [Abstract][Full Text] [Related]
13. Clickable Shiga Toxin B Subunit for Drug Delivery in Cancer Therapy. Danielewicz N; Rosato F; Tomisch J; Gräber J; Wiltschi B; Striedner G; Römer W; Mairhofer J ACS Omega; 2023 May; 8(17):15406-15421. PubMed ID: 37151527 [TBL] [Abstract][Full Text] [Related]
14. Potent in vitro antitumor activity of B-subunit of Shiga toxin conjugated to the diphtheria toxin against breast cancer. Mohseni Z; Sedighian H; Halabian R; Amani J; Behzadi E; Imani Fooladi AA Eur J Pharmacol; 2021 May; 899():174057. PubMed ID: 33753109 [TBL] [Abstract][Full Text] [Related]
15. Glycan-Adhering Lectins and Experimental Evaluation of a Lectin FimH Inhibitor in Enterohemorrhagic Park JY; Kim CH; Cho SH Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077327 [TBL] [Abstract][Full Text] [Related]
16. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor. Ashkenazi S; Cleary TG J Clin Microbiol; 1989 Jun; 27(6):1145-50. PubMed ID: 2666433 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide. Andrä J; Lohner K; Blondelle SE; Jerala R; Moriyon I; Koch MH; Garidel P; Brandenburg K Biochem J; 2005 Jan; 385(Pt 1):135-43. PubMed ID: 15344905 [TBL] [Abstract][Full Text] [Related]
19. Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains. Katagiri YU; Mori T; Nakajima H; Katagiri C; Taguchi T; Takeda T; Kiyokawa N; Fujimoto J J Biol Chem; 1999 Dec; 274(49):35278-82. PubMed ID: 10575015 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants. Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]